Ocata Therapeutics (OCAT) Reports Q3 Loss Per Share of $0.09
Tweet
Share
E-mailGet Alerts OCAT Hot Sheet
Join SI Premium – FREE
Ocata Therapeutics (NASDAQ: OCAT) reported Q3 EPS of ($0.09), versus ($0.13) reported last year.
For earnings history and earnings-related data on Ocata Therapeutics (OCAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- WhiteFiber, Inc. (WYFI) Misses Q2 EPS by 36c
- SunEdison (SUNE) Misses Q2 EPS by 52c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
